cells; depletion of vascular smooth muscle cells (VSMCs); and destruction of elastin lamellae, all of which contribute to aneurysm development. 5, 6 Genetic modification of macrophage mediators or surface receptors, such as angiopoietin-like protein-2, neurofibromin, and CD14, leads to changes in proinflammatory cytokines, matrix metalloproteinases (MMPs), reactive oxygen species (ROS), and adhesive properties of macrophages, thereby modulating the phenotype of experimental AAA. [7] [8] [9] Therefore, targeting vascular inflammation mediated by macrophages, the major inflammatory cells in AAA, may be a potential therapeutic approach for aneurysm pathologies. 10 Thrombomodulin (TM), constitutively expressed in endothelial cells (ECs) of the vasculature, was originally identified as a receptor of thrombin. TM is a membrane-bound glycoprotein structurally consisting of 5 domains, including an N-terminal C-type lectin-like domain, a domain with 6 epidermal growth factor-like structures, a serine-and threonine-rich domain, a transmembrane domain, and a cytoplasmic domain. 11 The epidermal growth factor-like domain of TM provides the binding site for thrombin. 12 The thrombin-TM complex may accelerate activation of protein C, a natural anticoagulant that inactivates coagulation factors Va and VIIIa, thereby inhibiting propagation of the coagulation cascades. 13 Activated protein C exerts a broad range of anti-inflammatory effects, such as reduction of proinflammatory cytokines and attenuation of leukocyte-EC adhesion. 14 In addition, TM also exhibits anti-inflammatory activities independent of activated protein C. Transgenic mice lacking the lectin-like domain of TM exhibited an increased sensitivity to tissue damage in sepsis and other experimental inflammatory models. 15 Moreover, recombinant soluble forms of TM domains can suppress inflammatory responses via inactivation of complement or neutralization of high-mobility group box 1 and Lewis Y carbohydrate. [16] [17] [18] Our previous works have demonstrated that recombinant soluble-form TM domains exert therapeutic effects in amelioration of various inflammatory disorders, including atherosclerosis, AAA, sepsis, and diabetic nephropathy. 12, [18] [19] [20] [21] Despite well-documented anti-inflammatory properties of soluble-form TM, the function and significance of membranebound TM in inflammatory responses remain largely undetermined. Studies have identified TM expression by monocytes and macrophages. [22] [23] [24] [25] The expression of membrane-bound TM in circulating monocytes in response to lipopolysaccharide stimulation or systemic inflammatory responses, such as cardiopulmonary bypass used for coronary artery bypass graft surgery and disseminated intravascular coagulopathy, has been evaluated, but the results and subsequent inferences were controversial. [22] [23] [24] Using lineage-restricted transgenic mice, however, we recently showed that loss of monocytic membrane-bound TM, which triggers lipopolysaccharide-and gram-negative bacteria-induced inflammatory responses, may prolong survival in experimental acute sepsis. 25 This discovery, inconsistent with the general understanding regarding anti-inflammatory functions of TM, raises the suspicion that membrane-bound TM in macrophages might positively regulate the molecular mechanisms underpinning the development of AAA and other macrophagepredominant chronic sterile inflammatory disorders.
In studies reported here, we attempted to gain insight into the significance of membrane-bound TM in AAA. We have investigated the hypothesis that membrane-bound TM in macrophages might be crucial in enhancing inflammatory responses during the development of aneurysm pathologies. Human abdominal aortic specimens were inspected for the potential relevance of membrane-bound TM in AAA. Also, the expression of TM was examined during the progression of experimental AAA in mice. Different cell lineage-restricted transgenic mice were generated to explore the impact of membrane-bound TM in mouse AAA models. In vitro studies were performed to explore the effects of membrane-bound TM deletion in macrophages on proinflammatory mediator production, cell adhesion, and ROS generation. These studies may help understand the functional significance of membrane-bound TM during the development of AAA.
Materials and Methods
Materials and Methods are available in the online-only Data Supplement.
Results

TM Is Expressed by VSMCs and Infiltrating Macrophages in Human AAA
First, we sought to investigate whether membrane-bound TM is relevant to human AAA. Double-immunofluorescent staining revealed that TM expression was highly restricted to intimal CD31-positive ECs but not in α-smooth muscle actinpositive VSMCs and CD68-positive macrophages in normal human abdominal aortic specimens ( Figure 1A-1I ). In human AAA specimens, however, no TM signal was found in intimal ECs. In contrast, TM expression was localized mainly to VSMCs and macrophages ( Figure 1J -1R). These findings implicated a role for membrane-bound TM in AAA formation.
TM Is Localized in Macrophages and VSMCs During AAA Development in Mice
Transient application of CaCl 2 periaortically on the infrarenal aorta has been a common experimental mouse AAA model, 5, 20, 26 with a consistent development of an aneurysm-like dilatation during a 28-day period. ECs, VSMCs, and macrophages are essential cellular components in the aortic and aneurysm wall. 27 Herein we used double-immunofluorescent staining to determine which cell type is the major source of membrane-bound TM at different timings during CaCl 2 -induced AAA formation in wild-type C57BL/6J mice. In the normal abdominal aorta, TM expression was predominantly detected in CD31-positive ECs ( 
Deficiency of Myeloid TM, not VSMC TM, Attenuates CaCl 2 -Induced AAA Formation in Mice
A complete loss of TM function in mice inevitably causes embryonic lethality within 10 days post coitum before establishment of a functional cardiovascular system. 28 Therefore, it is necessary to obtain transgenic mice with tissue-specific loss of TM to explore the role of membrane-bound TM in vivo. Transgenic mice with TM specifically ablated in myeloid cells (LysMcre/TM flox/flox mice, Mut 1 ) and their wild-type controls (TM flox/flox mice, WT 1 ) were generated to study whether membrane-bound TM in macrophages might contribute to CaCl 2induced AAA formation. Immunoblotting confirmed that TM was eliminated from macrophages in LysMcre/TM flox/flox mice ( Figure II in the online-only Data Supplement). The aortic diameters in TM flox/flox and LysMcre/TM flox/flox mice on day 0 before CaCl 2 injury were similar (0.52±0.01 mm versus 0.53±0.01 mm, n=12; P>0.05). However, on day 28 after AAA induction, the aortic diameter was significantly greater in TM flox/flox mice than in LysMcre/TM flox/flox mice (0.97±0.06 mm versus 0.67±0.03 mm, n=12; P<0.001; Figure 3A ). High concentrations of proinflammatory cytokines and increased infiltration of macrophages are prominent features in human AAA and the CaCl 2 -induced model. 6, 7, 9, 29 At 3 days, no differences existed in the aortic levels of tumor necrosis factor-α (TNF-α), interleukin-6, and monocyte chemotactic protein-1 between TM flox/flox and LysMcre/TM flox/flox mice. At 7 days and 28 days after AAA induction, the levels of Figure 2E ). At 7 days, the macrophage number in LysMcre/TM flox/flox mice was lower than that in TM flox/flox mice (7.2±1.0 versus 13.0±1.5 per HPF, n=5; P<0.05; Figure 3E ). At 28 days, the MOMA-2-positive macrophages were detected abundantly in TM flox/flox mice, and significantly fewer macrophages were observed in LysMcre/TM flox/flox mice (30.5±4.7 versus 10.3±1.6 per HPF, n=6; P<0.01; Figure 3E and 3F). In summary, analysis of the aortic samples obtained at different time points revealed that the progression of proinflammatory cytokine levels and macrophage recruitment accompanying with aneurysm development was greatly retarded in myeloid TM-deficient LysMcre/ TM flox/flox mice, suggesting that vascular inflammatory status was alleviated by myeloid TM deficiency. During CaCl 2 -induced AAA formation, MMP-9 and MMP-2 are both essential proteolytic enzymes for extracellular matrix degradation. 30 Analysis of the aortic samples at 28 days showed that the levels of total MMP-9 and MMP-2 were lower in LysMcre/TM flox/flox mice than in TM flox/flox mice, although the difference in MMP-2 did not reach significance ( Figure 3G ). In parallel to the results in MMPs, Verhoeff-Van Gieson staining for aortic samples of TM flox/flox mice at 28 days revealed disruption and discontinuity of elastin lamellae in the medial layer. In contrast, the integrity of elastin fibers In summary, myeloidspecific TM-deficient LysMcre/TM flox/flox mice were resistant to CaCl 2 -induced AAA formation, probably in association with reduction of macrophage accumulation, suppression of cytokine and MMP production, and attenuation of elastin degradation. TM expression was found in VSMCs in human AAA and in the CaCl 2 -induced model. Subsequently, transgenic mice with TM specifically ablated in VSMCs (SM22-cre tg /TM flox/flox mice, Mut 2 ), and their wild-type controls (SM22-cre tg /TM +/+ mice, WT 2 ) were also yielded to study whether membranebound TM in VSMCs might also be crucial in CaCl 2 -induced AAA formation. To determine the knockout efficiency of TM in VSMCs, aortic VSMCs from SM22-cre tg /TM flox/flox and SM22-cre tg /TM +/+ mice were isolated and then were analyzed using immunoblotting ( Figure IV in the online-only Data Supplement). The aortic diameters in SM22-cre tg /TM +/+ and SM22-cre tg /TM +/+ mice were not significantly different before CaCl 2 injury (0.53±0.02 mm versus 0.54±0.01 mm, n=8; P>0.05) and on day 28 after AAA induction (0.96±0.06 mm versus 0.90±0.04 mm, n=8; P>0.05; Figure 3H ). Likewise, analysis of aortic samples revealed that the levels of proinflammatory cytokines and MMPs in SM22-cre tg /TM +/+ and SM22-cre tg /TM flox/flox mice were not different on day 28 ( Figure VA In summary, deficiency of myeloid TM, but not VSMC TM, may confer protection against aortic dilatation induced by CaCl 2 , in agreement with our hypothesis that membranebound TM in macrophages is essential in the pathogenesis of AAA.
Genetic Blockade of TM in Macrophages Suppresses Production of Proinflammatory Mediators, Adhesion to ECs, and Generation of ROS
Infiltrating macrophages in AAA lesions have been identified as inflammatory macrophages and an important and primary source of proinflammatory mediators and oxidative stress. 7, 8, 10, 31, 32 Thioglycollate (TG)-induced peritoneal macrophages are bone marrow-derived inflammatory cells that produce proinflammatory cytokines, suggesting that their behaviors may resemble those of infiltrating macrophages in AAA. 7, 33 Because membrane-bound TM in infiltrating macrophages was critical in CaCl 2 -induced AAA formation, TM expression in inflammatory macrophages and in noninflammatory resident macrophages was assessed. As shown in Figure VI in the online-only Data Supplement, TG-induced peritoneal macrophages showed significantly increased TM expression compared with noninflammatory resident macrophages, suggesting that TG-induced peritoneal macrophages were a significant source of membrane-bound TM. We therefore used TG-induced peritoneal macrophages to explore possible mechanisms by which membrane-bound TM in macrophages mediates vascular inflammation during AAA formation. TG-induced peritoneal macrophages were obtained from TM flox/flox and LysMcre/TM flox/flox mice to determine whether membrane-bound TM in macrophages might modulate production of proinflammatory cytokines and MMPs. As measured using quantitative reverse transcriptase realtime polymerase chain reaction, a significant reduction in mRNA levels of proinflammatory cytokines (tnf-α, il-6, and mcp-1) was observed in macrophages from LysMcre/ TM flox/flox mice compared with those from TM flox/flox mice ( Figure 4A ). Although there was no difference in MMP-9 expression in peritoneal macrophages from the 2 genotypes, the expression of MMP-9 after stimulation with TNFα was significantly lower in TM-deficient macrophages ( Figure 4B ). These data suggested that membrane-bound TM may regulate proinflammatory mediator production in macrophages.
Adhesion to ECs is the first and critical step in monocyte/ macrophage recruitment. 34 Whether membrane-bound TM in monocytes/macrophages might affect adhesion to ECs was then evaluated. In the cell adhesion assay, TG-induced TM-deficient peritoneal macrophages from LysMcre/TM flox/flox mice exhibited a reduction in adhesion to the confluent EC monolayers composed of SVEC4-10 cells, a murine cell line of ECs, as compared with TM wild-type macrophages from TM flox/flox mice. In addition, this difference was more apparent after stimulation with TNF-α ( Figure 4C-4E) . The cell adhesion assay was repeated using THP-1 cells, a human monocytic cell line. Consistently, TM-knockdown THP-1 cells, versus THP-1 cells carrying luciferase-specific short hairpin RNA, exhibited a reduction in adhesion to the confluent EC monolayers constituted by human umbilical vein ECs ( Figure  VII in the online-only Data Supplement). Taken together, these data suggested that membrane-bound TM mediates monocyte/macrophage adhesion to ECs.
Oxidative stress with ROS accumulation has been crucial in aneurysm formation. 31 ROS, mainly produced from activated macrophages, are increased in human AAA and in the angiotensin II (AngII)-infused mouse model. 8, 32 Therefore, ROS production in TG-induced peritoneal macrophages from Figure 4F ).
In summary, these findings suggested that membranebound TM in monocytes/macrophages may regulate proinflammatory cytokine and MMP-9 production, adhesion to ECs, and intracellular ROS generation. Increase of arterial stiffness has been reported in the AngIIinfused model. 35 Figure 5A ). AngII infusion enhances vascular inflammation, MMP production, and oxidative stress in ApoE −/− mice. 8, 32, 36 Histological analysis of the suprarenal aortic samples after 28-day AngII infusion revealed that MOMA-2-positive macrophages were abundant in the medial and adventitial layers in ApoE −/− / TM flox/flox mice. However, the macrophage number was markedly reduced in ApoE −/− /LysMcre/TM flox/flox mice (30.0±1.9 versus 10.4±2.5 per HPF, n=5; P<0.01; Figure 5B . Taken together, these findings, consistent with in vitro results, suggested that myeloid TM in macrophages promotes AngII-infused AAA in hyperlipidemic mice, possibly through its action on macrophage recruitment, proinflammatory mediator production, and ROS generation.
Deletion of Myeloid TM Inhibits AngII-Infused AAA in ApoE −/− Mice
Together with the observations in the experimental AAA models in mice, these data suggest that macrophage inflammation mediated by membrane-bound TM might be considered a potential target to develop future pharmacotherapies for AAA.
Discussion
TM is originally considered a marker of normal ECs and may be dramatically downregulated in response to various inflammatory stimuli. 11 However, the expression or upregulation of TM in other cell types can be observed in different cardiovascular diseases. TM is upregulated in cardiomyocytes in patients with congestive heart failure and in mice after prolonged pressure overload. 37 The expression of TM in cultured VSMCs may be provoked by cyclooxygenase-2-derived prostaglandins, platelet-derived growth factor-BB, or several other substances. 38, 39 In human atherosclerotic lesions, TM expression is increased in macrophages and VSMCs but is reduced in ECs overlaying the atherosclerotic plaque. 38, 40, 41 In addition, upregulation of TM has been observed in VSMCs in mouse carotid arteries after carotid ligation and transverse aortic constriction, implicating a role of TM in the process of arterial remodeling. 42 In studies presented here, we attempt to investigate the spatiotemporal expression patterns of membrane-bound TM during aneurysm formation. Because human specimens obtained from surgical repair usually represent the end stage disease of AAA, established mouse models that well recapitulate different aspects of cellular and biochemical characteristics observed in human pathologies have been considered to be a platform to recognize the sequence of biological events during AAA development. 5 As might be expected, TM was predominantly expressed in resting ECs in the normal aorta, and endothelial TM was reduced in response to the CaCl 2 insult. Loss of VSMCs is a prominent feature in human AAA and in the CaCl 2 -induced model. 29 At the early stage, however, increased TM expression was observed in medial VSMCs. The short-term appearance of TM in VSMCs was followed by a lessening, probably in association with the quantitative reduction of VSMCs during the late stage of aneurysm formation. In contrast, TM expression in infiltrating macrophages sustained throughout the 28-day period of CaCl 2 -induced AAA development, compatible with the finding in human specimens. Circulating levels of soluble-form TM have been correlated to homocysteine levels and AAA sizes in a human study. 43 Our observations on human and mouse AAAs corroborate the participation of TM in AAA, as observed in other vascular disease entities, and provide a histological basis to study the functional significance of membrane-bound TM in VSMCs and macrophages, the 2 essential cell types involved in aneurysm development. 5, 27 For this purpose, we created cell lineage-restricted transgenic mice to elucidate the exact cell type expressing TM that is critical for AAA. Although increased TM expression in medial VSMCs has been transiently observed after CaCl 2 -induced vascular inflammation, mice deficient of VSMC TM exhibited no significant effects on experimental AAA formation. In addition, the levels of proinflammatory cytokines, MMPs, and elastin destruction in the aortic wall were not attenuated in VSMC-specific TM-deficient mice. These data suggested that membrane-bound TM in VSMCs may not play a decisive role in aneurysm formation. Conversely, histological analysis for the mouse model and human specimens demonstrated that increased TM signals were predominantly located in infiltrating macrophages in the aneurysm lesion. Also, upregulation of TM was found in TG-induced inflammatory peritoneal macrophages versus noninflammatory resident counterparts. Most important, the mice lacking membrane-bound TM expression in the myeloid lineage displayed an aneurysm-resistant phenotype. Macrophage-mediated inflammation during aneurysm development is featured with recruitment of monocytes/macrophages and production of a wide range of proinflammatory cytokines and proteinases that may sustain chronic vascular inflammation and extracellular matrix destruction. 5, 6, 20, 29 Through 2 different mouse AAA models, we demonstrated that myeloid membranebound TM may participate and play a decisive role in vascular inflammation during AAA formation. Taken together, the in vivo and in vitro findings suggested that, at several levels, membrane-bound TM in macrophages is likely to positively regulate macrophage inflammation. First, in vitro studies showed that deficiency of membrane-bound TM attenuated macrophage secretory products, including proinflammatory cytokines (TNFα, interleukin-6, and monocyte chemotactic protein-1) and MMP-9. These mediators have been critical in macrophage chemotaxis and elastolysis during the development of AAA. 30, 44, 45 Consistently, the aortic levels of proinflammatory cytokines and MMPs were suppressed in myeloid TM-deficient mice, resulting in abolishment of macrophage recruitment and maintenance of vascular integrity. Membrane-bound TM in macrophages is critical in regulating chronic inflammation and proteolytic degradation of extracellular matrix, the major pathological features in AAA. Second, myeloid cell recruitment and infiltration of the aortic wall to initiate elastin destruction are important steps in aneurysm formation, 8 and adhesion is the first and critical step in recruiting circulating leukocytes to specific sites of injury. 34 Blockade of membrane-bound TM in sterile inflammatory peritoneal macrophages and in THP-1 cells impeded monocyte/ macrophage adhesion to quiescent and activated ECs. In vivo macrophage accumulation was reduced in mice deficient of membrane-bound TM, suggesting that membrane-bound TM in monocytes/macrophages may be involved in the macrophage recruitment into the aneurysm lesion. Third, deficiency of membrane-bound TM in macrophages suppressed intracellular ROS generation in vitro. In the AngII-infused model, myeloid TM deletion reduced the production of proinflammatory cytokines and ROS in vivo. Overproduction of ROS has been detected in human AAA lesions and in the mouse AAA model induced by AngII infusion. 36 It has been reported that ROS may induce proinflammatory cytokine release in macrophages, and in turn, proinflammatory cytokines may activate macrophages to increase intracellular ROS. 46, 47 Membrane-bound TM may be critical in the production of both proinflammatory cytokines and ROS in macrophages, leading to the synergism that may accelerate AAA development. Based on these in vivo and in vitro observations, we propose potential mechanisms by which membrane-bound TM in macrophages may modulate macrophage inflammation during aneurysm formation and thus plays a pivotal role in AAA.
In a recent study, Schultz et al investigated whether deficiency of thrombin activatable fibrinolysis inhibitor (TAFI, or plasma procarboxypeptidase B), a natural fibronolytic inhibitor mainly produced by the liver and activated by thrombin/ TM complex, contributes to elastase-perfused AAA formation in mice. 48 Using mice with whole-body knockout of TAFI, the authors demonstrated that TAFI deficiency enhances AAA as the result of increased plasmin generation. Based on their observations and the well-known relationship between thrombin and TM, it is tempting to speculate that TM on the EC surface acts as a cofactor to activate TAFI that confers protection against AAA formation. 48 In the present study, however, we demonstrate the significance of membrane-bound TM that is specifically located in macrophages in AAA. In addition, our findings suggest the differential impact of membrane-bound TM in macrophages and VSMCs on AAA, implying that TM of different cells might function diversely during AAA formation. In fact, whether membrane-bound TM in macrophages is involved in TAFI activation like its EC counterpart remains unclear. Accordingly, the concept derived from studies reported by Schultz et al may not be necessarily contrary to the findings presented here.
Our study has some limitations. First, although ECs are one of the essential elements of the aortic vasculature and restoring the endothelial lining has been considered as a potentially effective therapy to stop AAA expansion, 27, 49 the role of endothelial TM in the pathogenesis of AAA remains undetermined. EC-specific TM-deficient mice display spontaneous juvenile-onset thrombosis followed by lethal consumptive coagulopathy at ≈3 weeks old. 28 The early occurrence of overt thrombosis before the ages suitable for AAA models excludes the possibility for EC TM-deficient mice to undergo AAA induction and following experiments. Second, in our previous study, short-term treatment with soluble recombinant TM domains 1, 2, and 3 (TMD123) has been an effective strategy in prevention and early treatment of the mouse CaCl 2 -induced AAA model. 20 Soluble recombinant TMD123, possibly through its inhibitory effect of TMD1 (the lectin-like domain) on high-mobility group box 1-receptor for advanced glycation end product signaling, 17 inhibits vascular inflammation and proteolysis, thereby conferring protection against AAA development. Interestingly, exogenous administration of soluble recombinant TMD1 enhances lipopolysaccharides and bacterial clearance, suppresses inflammatory responses, and reduces the mortality rate in Klebsiella pneumoniachallenged mice. 18 However, in another study, mice lacking endogenous TMD1 are protected from sepsis caused by melioidosis, implicating a detrimental role for TMD1 in the host response to sepsis. 50 Based on these observations, it is plausible that soluble recombinant TM domains at least in part act as decoy receptors, whereas membrane-bound TM could be a mediator in response to inflammatory stimuli. Our recent study has demonstrated that monocytic membrane-bound TM interacts with TLR4/CD14 complex and triggers gramnegative bacteria-induced inflammatory responses. 25 Further studies are warranted to provide molecular mechanisms by which membrane-bound TM in macrophages mediates sterile inflammatory responses in detail.
In conclusion, this study demonstrates a novel concept that membrane-bound TM positively regulates macrophage inflammation during AAA formation. Through targeted deletions of membrane-bound TM, we have understood the differential impact of membrane-bound TM in macrophages and VSMCs on aneurysm development in this study. Membranebound TM is predominantly expressed in macrophages in AAA, and myeloid TM deficiency confers protection against aneurysm formation in different mouse AAA models. Membrane-bound TM mediates macrophage-driven vascular inflammation in AAA, implicating the potential therapeutic application in macrophage-predominant chronic disorders.
